94 related articles for article (PubMed ID: 16503420)
81. Seven surprises in the TCR-centred regulation of immune responsiveness in an autoimmune system.
Sercarz E; Maverakis E; van den Elzen P; Madakamutil L; Kumar V
Novartis Found Symp; 2003; 252():165-71; discussion 171-6, 203-10. PubMed ID: 14609218
[TBL] [Abstract][Full Text] [Related]
82. Management of early inflammatory arthritis. Intervention with immunomodulatory agents: T cell vaccination.
Kingsley G; Panayi GS
Baillieres Clin Rheumatol; 1992 Jun; 6(2):435-54. PubMed ID: 1525847
[TBL] [Abstract][Full Text] [Related]
83. T cell receptor usage in autoimmune disease.
Olive C
Immunol Cell Biol; 1995 Aug; 73(4):297-307. PubMed ID: 7493765
[TBL] [Abstract][Full Text] [Related]
84. TCR peptide therapy in human autoimmune diseases.
Vandenbark AA; Morgan E; Bartholomew R; Bourdette D; Whitham R; Carlo D; Gold D; Hashim G; Offner H
Neurochem Res; 2001 Jun; 26(6):713-30. PubMed ID: 11519731
[TBL] [Abstract][Full Text] [Related]
85. Synthetic approaches to vaccines for infectious and autoimmune diseases.
Sela M; Arnon R
Vaccine; 1992; 10(14):991-9. PubMed ID: 1471429
[TBL] [Abstract][Full Text] [Related]
86. New approach to immunotherapy against organ-specific autoimmune diseases with T cell receptor and chemokine receptor DNA vaccines.
Matsumoto Y
Curr Drug Targets Immune Endocr Metabol Disord; 2005 Mar; 5(1):73-7. PubMed ID: 15777206
[TBL] [Abstract][Full Text] [Related]
87. TCR vaccination in aluminum adjuvant protects against autoimmune encephalomyelitis.
Aroeira LS
Clin Immunol; 2006 Jun; 119(3):252-60. PubMed ID: 16503420
[TBL] [Abstract][Full Text] [Related]
88. Protection from autoimmunity by DNA vaccination against T-cell receptor.
Buch T; Waisman A
Methods Mol Med; 2006; 127():269-80. PubMed ID: 16988460
[TBL] [Abstract][Full Text] [Related]
89. Immunoregulation by Vbeta specific antibodies in myasthenia gravis: mining physiological T cell homeostasis for TCR specific therapy.
Jambou F; Cohen-Kaminsky S
Cell Mol Biol (Noisy-le-grand); 2003 Mar; 49(2):181-92. PubMed ID: 12887101
[TBL] [Abstract][Full Text] [Related]
90. Antigen-specific therapies in multiple sclerosis: going beyond proteins and peptides.
Fontoura P; Garren H; Steinman L
Int Rev Immunol; 2005; 24(5-6):415-46. PubMed ID: 16318989
[TBL] [Abstract][Full Text] [Related]
91. Prospects for a T-cell receptor vaccination against myasthenia gravis.
Cohen-Kaminsky S; Jambou F
Expert Rev Vaccines; 2005 Aug; 4(4):473-92. PubMed ID: 16117705
[TBL] [Abstract][Full Text] [Related]
92. T cell receptor peptide therapy for autoimmune disease.
Vandenbark AA; Chou YK; Bourdette DN; Whitham R; Hashim GA; Offner H
J Autoimmun; 1992 Apr; 5 Suppl A():83-92. PubMed ID: 1503638
[TBL] [Abstract][Full Text] [Related]
93.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
94.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
